Strs Ohio Surmodics Inc Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Surmodics Inc stock. As of the latest transaction made, Strs Ohio holds 700 shares of SRDX stock, worth $26,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares

700

Previous 6,700 89.55%

Holding current value

$26,929

Previous $196,000 85.2%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$25.39 - $42.1 $152,340 - $252,600	-6,000 Reduced 89.55%	700 $29,000
Q1 2024 May 13, 2024	SELL	$27.44 - $35.56 $10,976 - $14,224	-400 Reduced 5.63%	6,700 $196,000
Q4 2023 Jan 30, 2024	BUY	$28.47 - $38.49 $99,645 - $134,715	3,500 Added 97.22%	7,100 $258,000
Q3 2021 Oct 22, 2021	BUY	$52.8 - $60.32 $132,000 - $150,800	2,500 Added 227.27%	3,600 $200,000
Q2 2021 Jul 26, 2021	BUY	$51.29 - $59.15 $56,419 - $65,065	1,100 New	1,100 $59,000
Q3 2019 Oct 21, 2019	SELL	$38.66 - $47.41 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$38.23 - $47.43 $481,697 - $597,618	-12,600 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$44.93 - $73.38 $35,944 - $58,704	800 Added 6.78%	12,600 $595,000
Q3 2018 Oct 19, 2018	SELL	$56.85 - $80.35 $227,400 - $321,400	-4,000 Reduced 25.32%	11,800 $880,000
Q2 2018 Aug 06, 2018	SELL	$35.85 - $57.05 $172,080 - $273,840	-4,800 Reduced 23.3%	15,800 $872,000
Q1 2018 Apr 20, 2018	SELL	$27.0 - $38.5 $86,400 - $123,200	-3,200 Reduced 13.45%	20,600 $783,000
Q4 2017 Jan 23, 2018	BUY	$28.0 - $33.2 $25,200 - $29,880	900 Added 3.93%	23,800 $666,000
Q3 2017 Oct 23, 2017	BUY	$24.5 - $31.1 $561,050 - $712,190	22,900	22,900 $709,000

Others Institutions Holding SRDX

# of Institutions

124

Shares Held

13.2M

Call Options Held

25.5K

Put Options Held

3.4K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $539M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account